Cited by 52Luminescence Properties of Advanced MaterialsNanoparticle-Based Drug DeliveryNanoplatforms for cancer theranostics

Phospholipase A2-Responsive Phosphate Micelle-Loaded UCNPs for Bioimaging of Prostate Cancer Cells

Open access
Sharipov, Mirkomil, Tawfik, Salah M., Gerelkhuu, Zayakhuu, Huy, Bui The, Lee, Yong-Ill·2017·Scientific Reports

Abstract

We report the effective synthesis of biocompatible upconversion nanoparticles (UCNP)-loaded phosphate micelles and successful delivery of UCNPs to prostate cancer cells via secreted phospholipase A2 (sPLA-2) enzyme cleavage of the loaded micelles for the first time. The activity of the (sPLA-2) enzyme toward the synthesized micelles was investigated and confirmed by LC-MS. TEM results showed that the micelles have a size distribution of 80 to 150 nm, whereas UCNP-loaded micelles range from 200 to 350 nm, indicating the successful loading of UCNPs. The selective release of UCNPs to prostate cancer cells rather than other cells, specifically cervical cancer cells, was observed and confirmed by a range of bioimaging studies. Moreover, cytotoxicity assays confirmed the biocompatibility of the UCNP-loaded micelles.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41598-017-16136-4

Cites

36 of 36 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The cytotoxicity results demonstrated that UCNPs-encapsulated phosphate micelles possess low toxicity toward prostate cancer cells.

    “The cytotoxicity results demonstrated that UCNPs-encapsulated phosphate micelles possess low toxicity toward prostate cancer cells.”

    From Recent Advances in Nanomicelles Delivery Systems. (2020) · cites this paper as [21]

  • Our group prepared a novel biocompatible micelles-based phosphate for UCNPs targeting to prostate cancer cells.

    “Our group [21] prepared a novel biocompatible micelles-based phosphate for UCNPs targeting to prostate cancer cells.”

    From Recent Advances in Nanomicelles Delivery Systems. (2020) · cites this paper as [21]

  • The developed micelles were found to be sPLA-2 enzyme responsive.

    “The developed micelles were found to be sPLA-2 enzyme responsive, as illustrated in Figure 16.”

    From Recent Advances in Nanomicelles Delivery Systems. (2020) · cites this paper as [21]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. [20]Zheng, F. et al. In NPG Asia Mater Vol. 9 e366 (The Author(s), 2017).

Cited by

Sorted by citations

Authors
Sharipov, M., Tawfik, S. M., Gerelkhuu, Z., Huy, B. T., & Lee, Y.-I.
Affiliations
Changwon National University (KR)
Corresponding author
Lee, Yong-Ill
Venue
Scientific Reports
Published
2017-11-22
Volume
7
Issue
1
Pages
16073-16073
ISSN
2045-2322 (ISSN-L)
OpenAlex
W2768680678
Cited by
52
References
36
Citations by year
2026: 2 · 2025: 4 · 2024: 6 · 2023: 3 · 2022: 11 · 2021: 13 · 2020: 3 · 2019: 4 · 2018: 6
FWCI
1.50
Type
journal article
Language
en
Open access
Locations
  • Scientific Reports (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • National Research Foundation
  • National Research Foundation of Korea ((NRF-2017R1A2B4006388)., 2017R1A2B4006388)
Topics
  • Physical Sciences › Materials Science › Materials Chemistry › Luminescence Properties of Advanced Materials
  • Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
  • Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics
Keywords
upconversion nanoparticles, secretory phospholipase A2, enzyme-responsive drug delivery, prostate cancer, bioimaging, targeted nanoparticle delivery, micelle size distribution, biocompatibility, cytotoxicity
MeSH terms
Bee Venoms, Diagnostic Imaging, Humans, Male, Micelles, Phosphates, Prostatic Neoplasms, Surface-Active Agents, Cell Death, Cell Line, Tumor, Nanoparticles, Phospholipases A2

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review